NewEdge Advisors’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
1CP
NRW
KIM
NewEdge Advisors's BME Position: Q1 2026 in Review
NewEdge Advisors reduced its BlackRock Health Sciences Trust (BME) stake by 8.9% in Q1 2026, selling an estimated $49.9K and leaving 12,326 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #2036.
NewEdge Advisors first reported a position in BME in Q4 2021 and has held it in 17 quarters since. The position peaked at $717K in Q4 2023. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.
- NewEdge Advisors held 12,326 shares of BlackRock Health Sciences Trust worth $475K as of Q1 2026.
- NewEdge Advisors sold 1,211 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $49.9K.
- BlackRock Health Sciences Trust made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #2036 holding.
- NewEdge Advisors first reported a position in BlackRock Health Sciences Trust in Q4 2021 and has held it in 17 quarters since.
- NewEdge Advisors's BlackRock Health Sciences Trust position peaked at $717K in Q4 2023.
- 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.
Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.